Search Results - "GEISEN, C"

Feasibility and efficiency of a preoperative anaemia walk-in clinic: secondary data from a prospective observational trial by Meybohm, P., Goehring, M.H., Choorapoikayil, S., Fischer, D., Rey, J., Herrmann, E., Mueller, M.M., Geisen, C., Schmitz-Rixen, T., Zacharowski, K.

Get full text

Association between phenotype and genotype in carriers of haemophilia A by MIESBACH, W., ALESCI, S., GEISEN, C., OLDENBURG, J.

“…Female carriers of haemophilia might suffer from increased bleeding tendency therefore the assessment of the bleeding risk is very important for improving…”
Get full text

Thirteen novel VKORC1 mutations associated with oral anticoagulant resistance: insights into improved patient diagnosis and treatment by WATZKA, M., GEISEN, C., BEVANS, C. G., SITTINGER, K., SPOHN, G., ROST, S., SEIFRIED, E., MÜLLER, C. R., OLDENBURG, J.

“…Background: Vitamin K 2,3‐epoxide reductase complex subunit 1 (VKORC1) is the molecular target of oral anticoagulants. Mutations in VKORC1 cause partial or…”
Get full text

The VKORC1 and CYP2C9 genotypes significantly effect Vitamin K antagonist dosing only in patients over the age of 20years by Nowak-Göttl, U., Dietrich, K., Kruempel, A., Geisen, C., Mitchell, L.G.

“…Given the qualitative differences in the role of VKORC1 and CYP2C9 polymorphisms in Vitamin K antagonists (VKA) dosing variation between adults and children,…”
Get full text

A uniform method for the simultaneous blood group phenotyping of Fya, Fyb, Jka, Jkb, S, s̅, P1, k applying lateral‐flow technique by Caesar, A., Meyer, S., Trost, N., Neuenschwander, K., Geisen, C., Frey, B. M., Gassner, C., Schwind, P.

“…Background and Objectives A lateral flow assay for simultaneous blood group typing of ABO, RhD, C, E, c, e, Cw and K with stable end‐point and without…”
Get full text

A uniform method for the simultaneous blood group phenotyping of Fy a , Fy b , Jk a , Jk b , S, s̅, P1, k applying lateral-flow technique by Caesar, A, Meyer, S, Trost, N, Neuenschwander, K, Geisen, C, Frey, B M, Gassner, C, Schwind, P

“…A lateral flow assay for simultaneous blood group typing of ABO, RhD, C, E, c, e, Cw and K with stable end-point and without centrifugation is in routine use…”
Get full text

Patient Blood Management in Europe: surveys on top indications for red blood cell use and Patient Blood Management organization and activities in seven European university hospitals by Bruun, M. T., Pendry, K., Georgsen, J., Manzini, P., Lorenzi, M., Wikman, A., Borg-Aquilina, D., van Pampus, E., van Kraaij, M., Fischer, D., Meybohm, P., Zacharowski, K., Geisen, C., Seifried, E., Liumbruno, G. M., Folléa, G., Grant-Casey, J., Babra, P., Murphy, M. F.

“…Background and Objectives Patient Blood Management (PBM) in Europe is a working group of the European Blood Alliance with the initial objective to identify the…”
Get full text

Pathogen-reduced Ebola virus convalescent plasma: first steps towards standardization of manufacturing and quality control including assessment of Ebola-specific neutralizing antibodies by Geisen, C., Kann, G., Strecker, T., Wolf, T., Schüttfort, G., van Kraaij, M., MacLennan, S., Rummler, S., Weinigel, C., Eickmann, M., Fehling, S. K., Krähling, V., Seidl, C., Seifried, E., Schmidt, M., Schäfer, R.

“…Background Ebola virus disease is a public health emergency of international concern, and enormous efforts are being made in the development of vaccines and…”
Get full text

Apheresis product identification in the transplant center: development of point-of-care protocols for extended blood typing of stem cell apheresis products by Cummerow, C, Schwind, P, Spicher, M, Spohn, G, Geisen, C, Seifried, E, Bönig, H

“…Transfusion of the ‘wrong’ stem cell product would almost inevitably be lethal, yet assays to confirm the contents of the product bag, except by checking…”
Get full text

Arterial thrombosis in homozygous antithrombin deficiency by Olivieri, M, Bidlingmaier, C, Schetzeck, S, Borggräfe, I, Geisen, C, Kurnik, K

“…Antithrombin (AT), a serin protease inhibitor (serpin) produced in the liver, inhibits mainly thrombin and factor Xa. Antithrombin deficiency (AD) is…”
Get more information

3.062 ATAXIN-2 INTERMEDIATE POLYGLUTAMINE EXPANSIONS CONTRIBUTE TO RISK OF ALS AND OF EARLY ONSET HEREDITARY PD by Gispert, S, Kurz, A, Waibel, S, Bauer, P, Liepelt, I, Geisen, C, Gitler, A.D, Becker, T, Weber, M, Berg, D, Andersen, P.M, Riess, O, Ludolph, A.C, Auburger, G

Get full text

DNA Excision Repair and DNA Damage-Induced Apoptosis Are Linked to Poly(ADP-Ribosyl)ation but Have Different Requirements for p53 by Beneke, Ralph, Geisen, Christoph, Zevnik, Branko, Bauch, Thomas, Müller, Wolfgang-Ulrich, Küpper, Jan-Heiner, Möröy, Tarik

“…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Mutational analysis of adeno-associated virus Rep protein-mediated inhibition of heterologous and homologous promoters by Hörer, M, Weger, S, Butz, K, Hoppe-Seyler, F, Geisen, C, Kleinschmidt, J A

“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Cerebral blood flow and glucose metabolism in multi-infarct-dementia related to primary antiphospholipid antibody syndrome by Hilker, R, Thiel, A, Geisen, C, Rudolf, J

“…The primary antiphospholipid antibody syndrome (PAPS) has beendescribed in patients with a history of fetal loss,thrombocytopenia and arterial or venous…”
Get full text

A novel point mutation in the 3' region of the prothrombin gene at position 20221 in a Lebanese/Syrian family by Wylenzek, M, Geisen, C, Stapenhorst, L, Wielckens, K, Klingler, K R

Get more information

Cost analysis of patient blood management by Kleinerüschkamp, A G, Zacharowski, K, Ettwein, C, Müller, M M, Geisen, C, Weber, C F, Meybohm, P

“…Patient blood management (PBM) is a multidisciplinary approach focusing on the diagnosis and treatment of preoperative anaemia, the minimisation of blood loss,…”
Get full text

Patient blood management: Current state of the literature by Meybohm, P, Fischer, D, Schnitzbauer, A, Zierer, A, Schmitz-Rixen, T, Bartsch, G, Geisen, C, Zacharowski, K

“…Preoperative anemia has a prevalence of approximately 30% and is one of the strongest predictors of perioperative red blood cell (RBC) transfusion. It is…”
Get full text

Cyclin E by Möröy, Tarik, Geisen, Christoph

“…E-type cyclins (cyclin E1 and cyclin E2) are expressed during the late G1 phase of the cell cycle until the end of the S-phase. The activity of cyclin E is…”
Get full text

In Vivo Labeling by CD73 Marks Multipotent Stromal Cells and Highlights Endothelial Heterogeneity in the Bone Marrow Niche by Breitbach, Martin, Kimura, Kenichi, Luis, Tiago C., Fuegemann, Christopher J., Woll, Petter S., Hesse, Michael, Facchini, Raffaella, Rieck, Sarah, Jobin, Katarzyna, Reinhardt, Julia, Ohneda, Osamu, Wenzel, Daniela, Geisen, Caroline, Kurts, Christian, Kastenmüller, Wolfgang, Hölzel, Michael, Jacobsen, Sten E.W., Fleischmann, Bernd K.

“…Despite much work studying ex vivo multipotent stromal cells (MSCs), the identity and characteristics of MSCs in vivo are not well defined. Here, we generated…”
Get full text

An HPA-1a–positive platelet–depleting agent for prevention of fetal and neonatal alloimmune thrombocytopenia: a randomized, single-blind, placebo–controlled, single-center, phase 1/2 proof-of-concept study by Geisen, Christof, Kjaer, Mette, Fleck, Erika, Skogen, Bjorn, Armstrong, Róisín, Behrens, Frank, Bhagwagar, Zubin, Braeuninger, Susanne, Mortberg, Anette, Olsen, Klaus Juel, Gastón Schäfer, Stephan Martin, Walter, Carmen, Seifried, Erhard, Wikman, Agneta, Kjeldsen-Kragh, Jens, Koehm, Michaela

“…Fetal/neonatal alloimmune thrombocytopenia (FNAIT) is a rare and potentially life-threatening bleeding disorder of the fetus/newborn. Antibodies against human…”
Get full text